AngioDynamics
ANGO
148 hedge funds and large institutions have $475M invested in AngioDynamics in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 70 increasing their positions, 32 reducing their positions, and 21 closing their positions.
600% more call options, than puts
Call options by funds: $7K | Put options by funds: $1K
119% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 32
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 149 → 148 (-1)
7.22% less ownership
Funds ownership: 95.35% → 88.12% (-7.2%)
38% less capital invested
Capital invested by funds: $760M → $475M (-$285M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$19M |
| 2 |
Millennium Management
New York
|
+$14.9M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.5M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.01M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$38.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.4M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$28.4M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.2M |
ANGO Hedge Fund Activity: Q4 2022 in Review
148 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2022, worth a combined $475M — down 38% from $760M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ANGO positions and 21 closed out — a net gain of 1 holder — while 70 added to existing stakes and 32 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $19M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $38.3M sold.
- 148 institutional investors held AngioDynamics (ANGO) as of Q4 2022, down from 149 in Q3 2022.
- Funds reported $475M of AngioDynamics stock for Q4 2022, down 38% quarter-over-quarter.
- 22 funds opened new AngioDynamics positions in Q4 2022 and 21 closed out, a net change of +1 holder.
- The largest AngioDynamics buyer in Q4 2022 was Victory Capital Management, an estimated $19M added.
- The largest AngioDynamics seller in Q4 2022 was Polar Capital Holdings, an estimated $38.3M sold.
Based on aggregated 13F filings for Q4 2022.